Full Text View
Tabular View
Study Results
Related Studies
PAR-101/OPT-80 Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD)
This study has been completed.
Study NCT00468728   Information provided by Optimer Pharmaceuticals

First Received on May 1, 2007.   Last Updated on August 8, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Clostridium Infections
Diarrhea
More general conditions related to this trial
Bacterial Infections
Gram-Positive Bacterial Infections
Signs and Symptoms
Signs and Symptoms, Digestive
Interventions listed in this trial
PAR-101/OPT-80
Vancomycin
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Optimer Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services